Low-quality evidence found to support use of cannabinoids for CINV
the ONA take:
According to a study published in the Journal of the American Medical Association, researchers have found moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and lower-quality evidence to support their use to treat chemotherapy-induced nausea and vomiting (CINV).
Cannabinoids are the active chemical compounds in marijuana.
For the study, researchers analyzed data from 79 trials that included 6,462 participants. Results of the meta-analysis showed that there was moderate-quality evidence to support the use of cannabinoids for the treatment of cancer pain. Researchers found low-quality evidence suggesting that cannabinoids improve CINV and very low-quality evidence to improve anxiety.
In regard to safety, cannabinoid use was associated with an increased risk of confusion, disorientation, dizziness, drowsiness, dry mouth, euphoria, fatigue, hallucination, loss of balance, nausea, and somnolence.
Moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|